PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32370011-0	2020	CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFkappaB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus.	bardoxolone methyl	0-7	nuclear factor kappa B subunit 1	Homo sapiens	79-87	
32370011-6	2020	Furthermore, CDDO-Me inhibited nuclear factor-kappaB (NFkappaB)-S276 phosphorylation and microglial transformation, independent of Nrf2 expression.	bardoxolone methyl	13-20	nuclear factor kappa B subunit 1	Homo sapiens	54-62	
32370011-8	2020	Therefore, these findings suggest, for the first time, that CDDO-Me may attenuate microglia/monocyte-mediated neuroinflammation via modulating NFkappaB- and p38 MAPK-MCP-1 signaling pathways following SE.	bardoxolone methyl	60-67	nuclear factor kappa B subunit 1	Homo sapiens	143-151